Home Partners Programmes About The Collective Institute Get in Touch
Futuremed Institute

Building the minds that build medtech

A knowledge platform for the medtech ecosystem — curated perspectives from practitioners, and structured education modules for founders inside incubators and academic programmes.

Perspectives Education Modules
Perspectives

Ideas that shape the medtech ecosystem

Insights, frameworks and viewpoints from the future.med network — for founders, investors and ecosystem builders navigating the commercialisation journey.

June 2026 Field Notes

IIM Bangalore NSRCEL Healthcare Cohort Bootcamp

We ran the opening bootcamp for NSRCEL's Healthcare Cohort at IIM Bangalore — a full-day session bringing together medtech founders, health-tech builders and healthcare entrepreneurs from across India.

The session covered market ecosystem mapping, the 4A-6P framework, and source of volume — anchored by real case studies and breakout exercises by therapeutic area.

This is the first of four sessions running through to the cohort's graduation presentation in Month 6.

40+Founders
4Sessions
IIM-BNSRCEL
Full class — IIM-B bootcamp
Participants Anil
Chaitanya presenting
Full lecture hall

IIM Bangalore NSRCEL · Healthcare Cohort · June 2026

Strategy · Commercialisation

What are you actually selling?

The Fundamental Entity question every MedTech founder skips

Alok Mishra  ·  Adjunct Associate Professor, Duke-NUS Medical School

Almost every MedTech founder, when asked “what are you selling?”, answers with a description of their device. Those are products. They’re not businesses. The gap between the two is where most MedTech startups quietly bleed out — not because the technology failed, but because they never decided who they are in the eyes of the person writing the check. This is the Fundamental Entity problem.

Read Article
Product-Market Fit · Commercialisation

Is Your Innovation a Fit?

The question every medtech founder needs to answer before going to market

Chaitanya Nimmakayala  ·  Founder, future.med Connect

One of the first questions we ask any medtech founder is: what problem is your technology solving? If the answer is about how cool and innovative the technology is — you probably need to spend more time inside the hospital and OT. Founders who have spent years perfecting a technology naturally see the world through it. The innovation is ready. The clinical need is obvious to them. But the market sees it differently.

Read Article
Education Modules

Structured programmes for incubators & accelerators

We design and run bespoke business-track modules inside academic and incubator settings — helping medtech founders build rigorous, fundable business plans from first principles.

01
Marketing Track
The Marketing Blueprint
Active at IIM-B 5–6 Months 4A-6P Framework
Currently Running At
IIM Bangalore · NSRCEL Healthcare Cohort, June 2026
Format
Bootcamp + 3 structured sessions across the cohort programme.
Built On
The 4A-6P Framework — Access, Adoption, Awareness, Affordability
Active · Bootcamp 26 June 2026

A structured marketing track for medtech founders — from market ecosystem and foundational strategy through to a complete marketing plan. Built on the 4A-6P framework.

Marketing Foundations — Objective, Volume & Differentiation
4A-6P market ecosystem, business objective, marketing objective & source of volume, main vs. dynamic variable, targeting & positioning.
Value Proposition
Differentiator, positioning, and field validation of customer segments.
Selling & Communication Plan
Sales approach, communication strategy, pitch development, and real-market testing.
Final Presentation
Complete marketing plan evaluated by a senior panel of industry and IIM-B experts.
Enquire about running this track Available for incubators and companies
02
Business Track
The Business Track
GTM Strategy Execution
Status
Launching at select incubators and companies in August 2026.
Focus
Go-to-market execution, distribution infrastructure, and real-world sales strategy for the Indian healthcare system.

Where marketing strategy meets real-world execution. This track takes founders from plan to market — building the GTM playbook, distribution strategy, and commercial infrastructure needed to actually sell in the Indian healthcare system.

Go-To-Market Strategy
Channel selection, customer prioritisation, pricing models, and market entry sequencing.
Distribution & Sales Infrastructure
Distribution networks, hospital procurement navigation, and channel partner selection.
Executional Playbook
Real-time sales tactics, objection handling, clinical champion strategy, and reimbursement pathways.
Final Presentation
Complete GTM plan with live market evidence, evaluated by industry practitioners and institutional partners.
Register your interest
03
Investor Track
Investor Readiness & Fundraising
Investment ThesisFundraising
Status
Available for cohorts and individual founders.
Focus
Translating regulatory, evidence, IP and GTM progress into a coherent investment narrative that stands up to real investor scrutiny.

The synthesis module. By this point founders have the regulatory status, evidence, IP position, and early go-to-market traction that make a real investment thesis possible.

Learning Objective
A founder can articulate a one-page investment thesis grounded in their commercial progress, and has stress-tested it against realistic investor scrutiny.
Deliverable
A one-page investment thesis, a stress-tested cap table and use-of-funds summary, and a rehearsed pitch ready to bring to a Futuremed Investor Circle session.
Enquire about this module Available for incubators and companies
04
Commercial Track
Hospital & Distributor Go-to-Market
Hospital GTMDistribution
Status
Available for cohorts and individual founders.
Focus
Mapping the hospital procurement decision unit, evaluating distributor options, and rehearsing a procurement-committee pitch.

Once founders have a regulatory clearance story and evidence package, the procurement pitch has substance behind it. This module builds the commercial muscle to convert that substance into revenue.

Learning Objective
A founder can map the hospital procurement decision unit for their device, has evaluated distributor options against a structured scorecard, and has rehearsed a procurement-committee pitch.
Deliverable
A completed decision-unit map for a target hospital segment, a distributor evaluation scorecard applied to 2–3 real candidates, and notes from the mock procurement pitch.
Enquire about this module Available for incubators and companies
05
Clinical Track
Clinical Evidence & KOL Engagement
Clinical EvidenceKOL Strategy
Status
Available for cohorts and individual founders.
Focus
Defining the minimum viable clinical evidence package and building a plan to engage KOLs whose backing makes that evidence credible.

The evidence tier required depends directly on the regulatory pathway and the target buyer. This module ensures founders invest in the right proof — not more, not less.

Learning Objective
A founder can define the minimum viable clinical evidence package for their target buyer and has a working plan to engage the KOLs whose backing will make that evidence credible.
Deliverable
A one-page evidence plan (target tier, current gap, data-collection plan) plus a named-KOL engagement tracker with next actions for each relationship.
Enquire about this module Available for incubators and companies
06
Regulatory Track
Regulatory & Compliance Navigation
CDSCORegulatory Pathway
Status
Available for cohorts and individual founders.
Focus
Regulatory classification, pathway mapping, and building a realistic timeline and cost estimate for advisors and investors.

Regulatory classification determines evidence requirements, timelines, and what investment-ready looks like downstream. Getting this right early saves years.

Learning Objective
A founder can articulate their device's risk classification, identify the applicable regulatory pathway(s), and produce a realistic timeline and cost estimate for advisors or investors.
Deliverable
A one-page regulatory roadmap — classification, pathway, estimated timeline, estimated cost — suitable to drop straight into an investor deck or Investor Circle conversation.
Enquire about this module Available for incubators and companies
07
IP Track
IP & Data Strategy
IP StrategyData Privacy
Status
Available for cohorts and individual founders.
Focus
Freedom-to-operate assessment, IP protection roadmap, and data privacy obligations for connected and software-enabled devices.

Founders should lock this down before deep hospital conversations or investor due diligence — gaps in IP and data strategy get exposed hardest in those settings.

Learning Objective
A founder can assess their freedom-to-operate position, has a basic IP protection roadmap, and understands the data/privacy obligations specific to their device category.
Deliverable
A completed freedom-to-operate self-assessment, a basic IP roadmap with filing priorities, and a data privacy/security checklist with flagged gaps and owners.
Enquire about this module Available for incubators and companies